Results 11 to 20 of about 257,933 (304)
Virology, 2006 Vaccination is the most effective medical intervention against diseases caused by human viral pathogens. Viral vaccines prevent or modify the severity of illness in the individual and interrupt or reduce the transmission of the pathogens to other susceptible people.
Arvin, Ann M., Greenberg, Harry B.
openaire +3 more sources
An Update on mRNA-Based Viral Vaccines. [PDF]
Vaccines (Basel), 2021 With the success of COVID-19 vaccines, newly created mRNA vaccines against other infectious diseases are beginning to emerge. Here, we review the structural elements required for designing mRNA vaccine constructs for effective in vitro synthetic ...
Jeeva S +4 more
europepmc +2 more sources
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines. [PDF]
Viruses, 2020 Live-attenuated vaccines (LAVs) have achieved remarkable successes in controlling virus spread, as well as for other applications such as cancer immunotherapy.
Mok DZL, Chan KR.
europepmc +2 more sources
Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines. [PDF]
Vaccines (Basel), 2020 Rapid obtaining of safe, effective, anti-viral vaccines has recently risen to the top of the international agenda. To maximize the success probability of future anti-viral vaccines, the anti-viral vaccines successful in the past are summarized here by ...
Serwer P.
europepmc +2 more sources
Open Life Sciences, 2022 In influenza vaccine development, Madin–Darby canine kidney (MDCK) cells provide multiple advantages, including large-scale production and egg independence. Several cell-based influenza vaccines have been approved worldwide.
Zhang Zhegang +19 more
doaj +1 more source
Viruses, 2022 The COVID-19 pandemic has highlighted the need for efficient vaccine platforms that can rapidly be developed and manufactured on a large scale to immunize the population against emerging viruses.
Julia P. C. Fulber, Amine A. Kamen
doaj +1 more source
npj Vaccines, 2021 Avian influenza A(H7N9) epidemics have a fatality rate of approximately 40%. Previous studies reported that low pathogenic avian influenza (LPAI)-derived candidate vaccine viruses (CVVs) are poorly immunogenic.
Peter Radvak +10 more
doaj +1 more source
A Review on Rubella Vaccine: Iran (1975-2019) [PDF]
Archives of Razi Institute, 2021 The first Attenuated rubella vaccine was developed by Parkman and Meyer in 1966. Ten years later in the 1975s, the rubella vaccine was developed in Razi Vaccine and serum research institute) RVSRI).
A Shafayi, A Mohammadi
doaj +1 more source
Capripoxvirus antibodies detection: Relationship between the two methods alpha and beta of virus neutralisation test [PDF]
Open Veterinary Journal, 2018 Virus neutralisation test (VNT) of capripoxvirus (CaPVs) was studied to assess the post-vaccination (vaccine effectiveness) or post-infection antibodies level using two methods: alpha-VNT and beta-VNT which are generally carried out to measure the ...
Mohamed Hamidouche +6 more
doaj +1 more source
Viruses, 2023 The influenza-specific antibody repertoire is continuously reshaped by infection and vaccination. The host immune response to contemporary viruses can be redirected to preferentially boost antibodies specific for viruses encountered early in life, a ...
Tal Einav +5 more
doaj +1 more source